Stockscreener 앱 받기
27.14
7.02%
-2.05
전일 마감가:
$29.19
열려 있는:
$29.14
하루 거래량:
871.35K
Relative Volume:
0.24
시가총액:
$2.18B
수익:
-
순이익/손실:
$-96.66M
주가수익비율:
-12.62
EPS:
-2.15
순현금흐름:
$-83.73M
1주 성능:
-3.35%
1개월 성능:
-20.83%
6개월 성능:
+495.18%
1년 성능:
+414.02%
1일 변동 폭
$27.04
$29.50
1주일 범위
$26.93
$29.50
52주 변동 폭
$2.86
$36.26
올레마 Stock (OLMA) Company Profile
명칭
Olema Pharmaceuticals Inc
전화
(415) 651-3316
주소
780 BRANNAN STREET, SAN FRANCISCO
OLMA을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
OLMA
Olema Pharmaceuticals Inc
|
27.14 | 2.34B | 0 | -96.66M | -83.73M | -2.15 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
올레마 Stock (OLMA) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-07 | 개시 | Piper Sandler | Overweight |
| 2025-10-08 | 개시 | Guggenheim | Buy |
| 2025-08-12 | 재확인 | Citigroup | Buy |
| 2024-04-02 | 개시 | Goldman | Buy |
| 2024-01-30 | 개시 | Citigroup | Buy |
| 2023-07-21 | 개시 | Oppenheimer | Outperform |
| 2023-05-05 | 개시 | CapitalOne | Overweight |
| 2023-02-22 | 개시 | Credit Suisse | Outperform |
| 2022-07-06 | 재개 | Canaccord Genuity | Buy |
| 2022-06-09 | 업그레이드 | H.C. Wainwright | Neutral → Buy |
| 2022-02-28 | 개시 | H.C. Wainwright | Neutral |
| 2021-12-07 | 재개 | Cowen | Outperform |
| 2020-12-14 | 개시 | Canaccord Genuity | Buy |
| 2020-12-14 | 개시 | Cowen | Outperform |
| 2020-12-14 | 개시 | JP Morgan | Overweight |
| 2020-12-14 | 개시 | Jefferies | Buy |
모두보기
올레마 주식(OLMA)의 최신 뉴스
Olema Pharmaceuticals director Harmon sells $101k in stock - Investing.com
Olema Pharmaceuticals director Harmon sells $101k in stock By Investing.com - Investing.com UK
Insider Sell Alert: Kovacs Shane William Charles Sells Shares of Olema Pharmaceuticals Inc (OLMA) - GuruFocus
Wall Street Remains Bullish on Olema Pharmaceuticals Inc. (OLMA) - Insider Monkey
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Insider Sells 3,822 Shares of Stock - MarketBeat
Olema Pharma CFO Kovacs sells shares worth $2.98 million By Investing.com - Investing.com India
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Insider Sells 100,000 Shares of Stock - MarketBeat
Olema Pharma CFO Kovacs sells shares worth $2.98 million - Investing.com
David Myles Sells 50,000 Shares of Olema Pharmaceuticals (NASDAQ:OLMA) Stock - MarketBeat
Olema Pharmaceuticals (NASDAQ:OLMA) Insider David Myles Sells 10,000 Shares - MarketBeat
Olema Pharma ch. discov. Myles sells shares worth $2.97 million - Investing.com
Stop Loss: Is Olema Pharmaceuticals Inc forming bullish engulfing patternsJuly 2025 Closing Moves & Free Fast Gain Swing Trade Alerts - baoquankhu1.vn
Will Olema Pharmaceuticals Inc. stock pay special dividendsGlobal Markets & Intraday High Probability Alerts - Bộ Nội Vụ
Aug Rallies: What are analysts price targets for Olema Pharmaceuticals IncJuly 2025 Highlights & Real-Time Volume Surge Alerts - baoquankhu1.vn
Olema Pharmaceuticals, Inc. (NASDAQ:OLMA) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
OLMA stock jumps 10% into JPMorgan week — what to watch for Olema Pharmaceuticals - TechStock²
Assessing Olema Pharmaceuticals (OLMA) Valuation After Analyst Upgrades And Recent Fundraising - Sahm
Olema Pharmaceuticals stock jumps 10% into JPM conference week: what OLMA traders are watching next - TechStock²
How Olema Pharmaceuticals Inc. stock performs during Fed tightening cycles2025 Year in Review & AI Enhanced Market Trend Forecasts - Улправда
Buy Signal: Will Olema Pharmaceuticals Inc. stock gain from government policiesMarket Sentiment Review & Weekly Top Gainers Alerts - Улправда
Cashing In at the Peak: Olema Pharmaceuticals Insiders Sell $8 Million in Stock After 300% Surge - FinancialContent
Olema Insider Sells $8 Million in Shares After 300% Stock Surge - Yahoo Finance
Olema Insider Sells $8 Million in Shares After 300% Stock Surge - The Motley Fool
Olema Pharmaceuticals (NASDAQ:OLMA) Raised to Strong-Buy at UBS Group - MarketBeat
How Bullish Analyst Coverage and New Capital Raise Could Impact Olema Pharmaceuticals (OLMA) Investors - Yahoo Finance
Olema Pharmaceuticals, Inc.Common Stock (NQ: OLMA - FinancialContent
Olema Pharmaceuticals (NASDAQ:OLMA) Stock Price Down 8.6%Here's What Happened - MarketBeat
Wall Street Analysts See a 386.42% Upside in Olema Pharmaceuticals (OLMA): Can the Stock Really Move This High? - MSN
Pfizer collaboration with Olema may spark future bidding waranalyst - MSN
UBS Initiates Coverage on Olema Pharmaceuticals (OLMA) with a 'B - GuruFocus
Olema Pharmaceuticals (NASDAQ:OLMA) Coverage Initiated by Analysts at Piper Sandler - MarketBeat
Piper Sandler initiates Olema Pharmaceuticals stock with Overweight rating By Investing.com - Investing.com Canada
UBS initiates Olema Pharmaceuticals stock with Buy rating, $45 target By Investing.com - Investing.com Canada
Olema Oncology (OLMA) Targeted for Growth with $60 Price Objecti - GuruFocus
Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Sahm
Olema Oncology reports inducement grants under Nasdaq Listing Rule 5635(c)(4) - MarketScreener
Olema Pharmaceuticals to Present at 44th Annual J.P. Morgan Healthcare Conference - Quiver Quantitative
Olema Oncology to Present at 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Biotech Olema gives 8 new employees long-term stock option deals - Stock Titan
Insider Selling: Olema Pharmaceuticals (NASDAQ:OLMA) Director Sells 2,881 Shares of Stock - MarketBeat
Olema Pharmaceuticals director Harmon sells $82,194 in stock By Investing.com - Investing.com Nigeria
Olema Pharmaceuticals director Harmon sells $82,194 in stock - Investing.com India
Olema Pharmaceuticals (OLMA) Stock: Weekend Read Ahead on the Pullback, Insider Sales, and Wall Street Targets Before Monday’s Open - ts2.tech
Olema Pharmaceuticals (OLMA) Stock Update: Weekend Snapshot, Insider Sales, Analyst Targets, and Key Catalysts Ahead of Monday - ts2.tech
Will Olema Pharmaceuticals’ (OLMA) Index Debut Quietly Redefine Its Standing Among Biotech Investors? - simplywall.st
Olema: 'Strong Buy' Maintained On OPERA-02 Trial Initiation & Additional Shots On Goal - Seeking Alpha
Olema Pharmaceuticals Insider Sold Shares Worth $1,553,544, According to a Recent SEC Filing - marketscreener.com
Olema Pharmaceuticals Insider Sold Shares Worth $7,873,109, According to a Recent SEC Filing - marketscreener.com
Olema Pharmaceuticals Insider Sold Shares Worth $7,530,148, According to a Recent SEC Filing - marketscreener.com
Olema pharma chief medical officer sells shares for $7.5m By Investing.com - Investing.com South Africa
올레마 (OLMA) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):